References
- 1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. DOI: 10.1016/j. diabres.2009.10.007
- 2. Green A, Patterson CC; EURODIAB TIGER Study Group. Europe and Diabetes. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 2001 Oct;44(Suppl 3):B3-8. DOI: 10.1007/ PL0000295010.1007/PL00002950
- 3. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, et al. Heterogeneity of type I diabetes: Analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar;44(3):354-62. DOI: 10.1007/s00125005162610.1007/s001250051626
- 4. Atkinson M, Eisenbarth G. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001 Jul;358(9277):221-9. DOI: 10.1016/S0140-6736(01)05415-010.1016/S0140-6736(01)05415-0
- 5. The Diabetes Prevention Trial-Type 1 Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002 May;346(22):1685-91. DOI: 10.1056/NEJMoa01235010.1056/NEJMoa01235012037147
- 6. Lenze S. The mechanisms of alloxan- and streptozotocin- induced diabetes. Diabetologia. 2008 Feb;51(2):216-26. DOI: 10.1007/s00125-007-0886-710.1007/s00125-007-0886-718087688
- 7. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003;12(1):44-50. DOI: 10.1046/j.1444-2892.2003.00160.x10.1046/j.1444-2892.2003.00160.x16352106
- 8. Bahey NG, Soliman GM, El-Deeb TA, El-Drieny EA. Influence of insulin and testosterone on diabetic rat ventral prostate: Histological, morphometric and immunohistochemical study. Journal of Microscopy and Ultrastructure. 2014;2(3):151-60. DOI: 10.1016/j. jmau.2014.06.002
- 9. Moorhead KT, Hill JV, Chase JG, Hann CE, Scotter JM, Storer MK, et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput Methods Programs Biomed. 2011 Feb;101(2):173-82. DOI: 10.1016/j.cmpb.2010.07.01010.1016/j.cmpb.2010.07.01020728235
- 10. Boroujeni NB, Hashemi SM, Khaki Z, Soleimani M. The reversal of hyperglycemia after transplantation of mouse embryonic stem cells induced into early hepatocyte- like cells in streptozotocin-induced diabetic mice. Tissue Cell. 2011 Apr;43(2):75-82. DOI: 10.1016/j. tice.2010.12.002
- 11. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000 Dec;43(12):1528-33. DOI: 10.1007/ s00125005156410.1007/s00125005156411151762
- 12. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord. 2013 Dec;12(1):60. DOI: 10.1186/2251-6581-12-6010.1186/2251-6581-12-60796247424364898
- 13. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 1967 Oct;126(1):201-5. DOI: 10.3181/00379727-126-3240110.3181/00379727-126-324014864021
- 14. Huang M, Gao L, Yang L, Lin F, Lei H. Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging. Neuroimage Clin. 2012 Sep;1(1):57-65. DOI: 10.1016/j. nicl.2012.09.004
- 15. Ávila Dde L, Araújo GR, Silva M, Miranda PH, Diniz MF, Pedrosa ML, et al. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Arch Med Res. 2013 Apr;44(3):194-202. DOI: 10.1016/j.arcmed.2013.03.00410.1016/j.arcmed.2013.03.004
- 16. Yono M, Pouresmail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):251-5. DOI: 10.1007/s00210-005-0010-910.1007/s00210-005-0010-9
- 17. Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, et al. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007 Oct;30(10):2706-7. DOI: 10.2337/dc07-003010.2337/dc07-0030
- 18. Raghunathan S, Tank P, Bhadada S, Patel B. Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int. 2014;2014:948427. DOI: 10.1155/2014/94842710.1155/2014/948427
- 19. Cameron NE, Cotter MA. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J Diab Complic. 2001 Jul-Aug;15(4):198-202. DOI: 10.1016/S1056-8727(01)00149-010.1016/S1056-8727(01)00149-0
- 20. Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin- diabetic rats. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. DOI: 10.1152/ajpendo.00479.200710.1152/ajpendo.00479.200717911342
- 21. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K, Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology. 1996 Mar;110(3):885-93. DOI: 10.1053/gast.1996.v110.pm8608899 10.1053/gast.1996.v110.pm86088998608899